Manmeet S. Soni
Overview
Manmeet S. Soni received an average of $7M in total compensation, including $541K in salary, at REATA PHARMACEUTICALS from 2019 to 2021. Manmeet Soni also received $4M at Alnylam Pharmaceuticals in 2017.
- 2021
- 2020
- 2019
- 2017
REATA PHARMACEUTICALSChief Operation Officer, Chief Financial Officer and President
REATA PHARMACEUTICALSChief Operation Officer, Chief Financial Officer and Executive Vice President
REATA PHARMACEUTICALSChief Financial Officer and Executive Vice President
Alnylam PharmaceuticalsSenior Vice President, Chief Financial Officer principal financial officer
Source: SEC filings on April 29, 2022, April 30, 2021, April 29, 2020, and March 23, 2018.
Related executives
We found 19 more executives who work or worked at REATA PHARMACEUTICALS and Alnylam Pharmaceuticals.
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
J Huff
REATA PHARMACEUTICALS
Chief Executive Officer
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
Colin Meyer
REATA PHARMACEUTICALS
Chief Innovation Officer and Executive Vice President
Dawn Bir
REATA PHARMACEUTICALS